H. Alzuhair et He. Mohamed, VITAMIN-C ATTENUATION OF THE DEVELOPMENT OF TYPE-I DIABETES-MELLITUS BY INTERFERON-ALPHA, Pharmacological research, 38(1), 1998, pp. 59-64
Interferon alpha (IFN-alpha) inhibits insulin release and may be cytot
oxic to pancreatic islets. Increased free radical activity may be impl
icated in the cytotoxic action of IFN-alpha and development of diabete
s mellitus. Therefore we measured markers of free radical activity (li
pid peroxides and the non-peroxide-conjugated diene isomer of linoleic
acid [PL-9,11-LA']) along with some pancreatic variables in male albi
no rats treated with IFN-alpha, as well as the possible protective eff
ect of two antioxidants, vitamin C and mannitol. Compared to untreated
rats, it was shown that IFN-alpha induced an increase in plasma gluco
se. Pancreatic and serum insulin, as well as serum C-peptide, were inc
reased after 1 week, then their levels were reduced after 2 weeks. Pla
sma lipid peroxides and (PL-9,11-LA') were markedly elevated, while li
noleic acid was reduced. These changes in the studied parameters were
attributed, in part, to the superoxide and free radical generation dur
ing IFN-alpha treatment. Plasma glucagon was increased after 2 weeks.
Administration of vitamin C along with IFN-alpha succeeded in modulati
ng most of the altered parameters affected during IFN-alpha. The hyper
glycaemic effect of IFN-alpha was greatly ameliorated and the negative
effect on pancreatic and serum insulin and serum C-peptide were nearl
y abolished. The elevated levels of lipid peroxide and (PL-9,11-LA') a
nd the reduction in linoleic acid being normalised. The only persisten
t effect was the increase in plasma glucagon. Concurrent administratio
n of mannitol with IFN-alpha caused no changes in the parameters studi
ed compared to that induced by treatment with IFN-alpha alone. (C) 199
8 The Italian Pharmacological Society.